Privia Health Group, Inc. (PRVA) intrinsic value & 10-year financials
Privia Health Group, Inc. (PRVA) has a Graham intrinsic value of $5.12 per share. At $22.52 on Oct 17, 2026, the stock trades 340% above that value. Over the last 8 fiscal years revenue grew 18.0% a year to $2.1B, with an average return on invested capital of -18.2%.
- Graham intrinsic value
- $5.12
- Share price (Oct 17, 2026)
- $22.52
- Price vs Graham value
- 340% above
- Market cap
- $2.9B
- Revenue (FY2025)
- $2.1B
- Revenue growth (8-yr CAGR)
- 18.0%
- ROIC (10-yr avg)
- -18.2%
- Free cash flow (FY2025)
- —
PRVA 10-year financial history
| Fiscal year | Revenue | Net income | EPS (diluted) | Free cash flow | Operating margin | ROIC |
|---|---|---|---|---|---|---|
| FY2025 | $2.1B | $22.9M | $0.18 | — | 1.6% | 10.3% |
| FY2024 | $1.7B | $14.4M | $0.11 | — | 1.0% | 6.0% |
| FY2023 | $1.7B | $23.1M | $0.19 | $80.7M | 1.2% | 9.1% |
| FY2022 | $1.4B | -$8.6M | -$0.08 | $47.1M | -1.4% | -7.0% |
| FY2021 | $966.2M | -$188.2M | -$1.83 | $54.5M | -22.5% | -154.2% |
| FY2020 | $817.1M | $31.2M | $0.33 | $38.5M | 3.1% | 26.5% |
| FY2019 | $786.4M | $8.2M | $0.09 | $18.6M | 2.0% | — |
| FY2018 | — | — | — | — | — | — |
Source: annual 10-K filings on SEC EDGAR. Figures in USD.
Executive summary
Privia Health Group, Inc. revenue growth over the past decade is N/A; insufficient history prevents a reliable 10-year CAGR calculation.
Privia Health Group, Inc. has historically struggled to out-earn its cost of capital, averaging just 7.2% ROIC.
Privia Health Group, Inc. capital allocation metrics are N/A for the decade; share count and net debt history are incomplete.
Benjamin Graham lens
Under Benjamin Graham's formula using SEC EDGAR fundamentals, Privia Health Group, Inc. is modeled at 12.2% normalized earnings growth with a 5.1% bond-yield adjustment. The resulting Graham intrinsic value estimate is $5.12 per share.